Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable ...

Investigators from the laboratory of Derek Walsh, Ph.D., professor of Microbiology-Immunology, have discovered how human ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

When Leanne Pook turned 30, she was newly single and increasingly anxious that her chance to have a baby was slipping away.

Vir Biotechnology, Inc. today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive license for ...

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals.Vir Biotechnology's chronic hepatitis ...